BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 26376676)

  • 21. Sorafenib inhibits growth and metastasis of hepatocellular carcinoma by blocking STAT3.
    Gu FM; Li QL; Gao Q; Jiang JH; Huang XY; Pan JF; Fan J; Zhou J
    World J Gastroenterol; 2011 Sep; 17(34):3922-32. PubMed ID: 22025881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.
    Rajendran P; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Ahn KS; Kumar AP; Sethi G
    J Cell Physiol; 2012 May; 227(5):2184-95. PubMed ID: 21792937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
    Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
    Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma.
    Li H; Liu Y; Jiang W; Xue J; Cheng Y; Wang J; Yang R; Zhang X
    BMC Cancer; 2021 Mar; 21(1):318. PubMed ID: 33765973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling.
    Tan ZB; Fan HJ; Wu YT; Xie LP; Bi YM; Xu HL; Chen HM; Li J; Liu B; Zhou YC
    J Ethnopharmacol; 2019 Mar; 232():62-72. PubMed ID: 30553869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (-)-Oleocanthal inhibits growth and metastasis by blocking activation of STAT3 in human hepatocellular carcinoma.
    Pei T; Meng Q; Han J; Sun H; Li L; Song R; Sun B; Pan S; Liang D; Liu L
    Oncotarget; 2016 Jul; 7(28):43475-43491. PubMed ID: 27259268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cantharidin treatment inhibits hepatocellular carcinoma development by regulating the JAK2/STAT3 and PI3K/Akt pathways in an EphB4-dependent manner.
    Zhu M; Shi X; Gong Z; Su Q; Yu R; Wang B; Yang T; Dai B; Zhan Y; Zhang D; Zhang Y
    Pharmacol Res; 2020 Aug; 158():104868. PubMed ID: 32407961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway.
    Zhao Z; Song J; Tang B; Fang S; Zhang D; Zheng L; Wu F; Gao Y; Chen C; Hu X; Weng Q; Yang Y; Tu J; Ji J
    J Exp Clin Cancer Res; 2020 Nov; 39(1):259. PubMed ID: 33234142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Icaritin shows potent anti-leukemia activity on chronic myeloid leukemia in vitro and in vivo by regulating MAPK/ERK/JNK and JAK2/STAT3 /AKT signalings.
    Zhu Jf; Li Zj; Zhang Gs; Meng K; Kuang Wy; Li J; Zhou Xf; Li Rj; Peng Hl; Dai Cw; Shen JK; Gong Fj; Xu Yx; Liu Sf
    PLoS One; 2011; 6(8):e23720. PubMed ID: 21887305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GYY4137, a hydrogen sulfide (H₂S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway.
    Lu S; Gao Y; Huang X; Wang X
    Int J Oncol; 2014 Apr; 44(4):1259-67. PubMed ID: 24535538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitidine chloride inhibits hepatocellular carcinoma cell growth in vivo through the suppression of the JAK1/STAT3 signaling pathway.
    Liao J; Xu T; Zheng JX; Lin JM; Cai QY; Yu DB; Peng J
    Int J Mol Med; 2013 Jul; 32(1):79-84. PubMed ID: 23613111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticancer activity of dietary xanthone α-mangostin against hepatocellular carcinoma by inhibition of STAT3 signaling via stabilization of SHP1.
    Zhang H; Tan YP; Zhao L; Wang L; Fu NJ; Zheng SP; Shen XF
    Cell Death Dis; 2020 Jan; 11(1):63. PubMed ID: 31980595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway.
    Yang X; Liang L; Zhang XF; Jia HL; Qin Y; Zhu XC; Gao XM; Qiao P; Zheng Y; Sheng YY; Wei JW; Zhou HJ; Ren N; Ye QH; Dong QZ; Qin LX
    Hepatology; 2013 Jul; 58(1):158-70. PubMed ID: 23389848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticancer agent icaritin induces apoptosis through caspase-dependent pathways in human hepatocellular carcinoma cells.
    Sun L; Peng Q; Qu L; Gong L; Si J
    Mol Med Rep; 2015 Apr; 11(4):3094-100. PubMed ID: 25434584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of antitumor activity of Artemisia capillaris extract against hepatocellular carcinoma through the inhibition of IL-6/STAT3 signaling axis.
    Jang E; Kim SY; Lee NR; Yi CM; Hong DR; Lee WS; Kim JH; Lee KT; Kim BJ; Lee JH; Inn KS
    Oncol Rep; 2017 Jan; 37(1):526-532. PubMed ID: 28004112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Norcantharidin inhibits IL-6-induced epithelial‑mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells.
    Gao Y; Li W; Liu R; Guo Q; Li J; Bao Y; Zheng H; Jiang S; Hua B
    Oncol Rep; 2017 Aug; 38(2):1224-1232. PubMed ID: 28677802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A sesquiterpene lactone antrocin from Antrodia camphorata negatively modulates JAK2/STAT3 signaling via microRNA let-7c and induces apoptosis in lung cancer cells.
    Yeh CT; Huang WC; Rao YK; Ye M; Lee WH; Wang LS; Tzeng DT; Wu CH; Shieh YS; Huang CY; Chen YJ; Hsiao M; Wu AT; Yang Z; Tzeng YM
    Carcinogenesis; 2013 Dec; 34(12):2918-28. PubMed ID: 23880305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kurarinol induces hepatocellular carcinoma cell apoptosis through suppressing cellular signal transducer and activator of transcription 3 signaling.
    Shu G; Yang J; Zhao W; Xu C; Hong Z; Mei Z; Yang X
    Toxicol Appl Pharmacol; 2014 Dec; 281(2):157-65. PubMed ID: 24997323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3.
    Dai X; Ahn KS; Kim C; Siveen KS; Ong TH; Shanmugam MK; Li F; Shi J; Kumar AP; Wang LZ; Goh BC; Magae J; Hui KM; Sethi G
    Mol Oncol; 2015 Apr; 9(4):818-33. PubMed ID: 25624051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NLRC3 silencing accelerates the invasion of hepatocellular carcinoma cell via IL-6/JAK2/STAT3 pathway activation.
    Kang JH; Li MJ; Luan PP; Jiang DK; Chen YW; Xu X; Yu Q; Xu YW; Su Q; Peng WH; Jian WX
    Cell Biol Int; 2020 Oct; 44(10):2053-2064. PubMed ID: 32584509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.